However, among patients with MYCN-amplified low-stage NB, the outcome was significantly better for patients with hyperdiploid tumors when compared to those with diploid tumors (5), suggesting that tumor-cell ploidy could potentially improve risk classification. Here, MYCN is linked to neuroblastoma.